Johnson & Johnson Prepares To Release COVID Vaccine Trial Data, While US Announces Changes To Vaccination Policy 14/01/2021 Madeleine Hoecklin Johnson & Johnson is set to release its Phase 3 COVID-19 clinical trial results in two weeks and immediately file for emergency authorization from the US Food and Drug Administration (FDA) – an announcement that is likely a harbinger of positive results. This news on the development of the first one-shot COVID-19 vaccine, accompanied by […] Continue reading -> Israel As Global Guinea Pig – Data On Initial COVID-19 Vaccines Encouraging – But Infections Still Surging 13/01/2021 Elaine Ruth Fletcher JERUSALEM – Racing ahead in a relentless vaccine campaign that has made it a global leader, Israel has now administered an initial COVID-19 jab to nearly 2 million people – about 20% of its population, including 70% of people over the age of 60. And it is set to have some 5.2 million people completely […] Continue reading -> Rapid Increase In COVID Cases ‘Not Due To The Variant’, WHO Says 12/01/2021 J Hacker The “almost vertical” spike in SARS-CoV-2 infections seen in many countries over the last few weeks is largely due to increased social contact and not virus mutations, WHO has said. Speaking at a media briefing on Monday, Dr Maria Van Kerkhove, WHO’s COVID-19 Technical Lead, stated that sharp increases in transmission had occurred in a […] Continue reading -> Switzerland Approves Moderna COVID Vaccine, As Pharma Company Claims Vaccine Could Confer Year Of Immunity – At Least 12/01/2021 J Hacker Switzerland’s drug regulatory agency, Swissmedic, has authorized Moderna’s mRNA COVID-19 vaccine for use – in a move that should helop accelerate its rollout of vaccines against the pandemic, The Swiss Federal Government has secured 7.5 million doses of the Moderna vaccine, with deliveries expected to begin next week from the Visp-based plant where most of […] Continue reading -> €93 Billion Spent By Public Sector On COVID Vaccines and Therapeutics in 11 Months, Research Finds 12/01/2021 Madeleine Hoecklin Governments have spent at least €93 billion on COVID-19 vaccines and therapeutics globally since the beginning of the pandemic, a new study has found. Research published on Monday by the kENUP Foundation, a European non-profit supporting research-based innovation in health industries, found that in 11 months, the public sector invested heavily in the development of […] Continue reading -> COVID Extremes: Most Hospitalized Patients Still Have Symptoms 6 Months Later; But Asymptomatic Cases Are Driving Transmission 09/01/2021 Madeleine Hoecklin Two new studies published this week highlight the challenges to health policy posed by COVID-19 – with seriously ill COVID-19 patients continuing to suffer with “Long COVID” months after being released from the hospital – while completely asymptomatic cases drive more than half of overall disease transmission. More than three quarters of patients diagnosed with […] Continue reading -> EMA Approves Moderna’s COVID-19 Vaccine – US Experts Examine Halving Doses To Extend Supplies 06/01/2021 Madeleine Hoecklin The European Medicines Agency (EMA), the EU drug regulator, recommended issuing a conditional marketing authorization for Moderna’s COVID-19 vaccine, which follows the authorization of the Pfizer-BioNTech vaccine in late December. “This vaccine provides us with another tool to overcome the current emergency,” Emer Cooke, Executive Director of EMA, said in the press release. “It is […] Continue reading -> People Who Have Had COVID Can Delay Vaccine Up To 6 Months, Says WHO 05/01/2021 J Hacker Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 People who have recently had a confirmed COVID-19 infection can choose to delay vaccination, so as to allow others who are not immune take advantage of initial procurements, WHO has recommended. Following WHO’s approval of the Pfizer/BioNTech vaccine last week, its strategic advisory group of experts (SAGE) said that if a person has had a […] Continue reading -> Israel Approves Moderna’s COVID-19 Vaccine – First Country Outside North America 05/01/2021 Elaine Ruth Fletcher BREAKING – Israel’s Ministry of Health on Tuesday approved the administration of Moderna’s COVID-19 vaccine, making it the first country outside of North America to greenlight the US-based startup’s candidate. The announcement by Moderna said that deliveries of the vaccine to Israel would begin already in January – sharply advancing a schedule that was originally […] Continue reading -> UK Delay of Second COVID-19 Vaccine Dose – A Risky Strategy That Could Give Rise To More Virus Mutations, Some Experts Warn 04/01/2021 Madeleine Hoecklin The United Kingdom’s decision to delay the second dose of the Pfizer/BioNTech COVID-19 vaccine being rolled out en masse in the nation is a risky strategy – not only for those getting the vaccine, but also in terms of the longer-term public health impacts such delays could have in terms of future SARS-CoV2 mutations, some […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Israel As Global Guinea Pig – Data On Initial COVID-19 Vaccines Encouraging – But Infections Still Surging 13/01/2021 Elaine Ruth Fletcher JERUSALEM – Racing ahead in a relentless vaccine campaign that has made it a global leader, Israel has now administered an initial COVID-19 jab to nearly 2 million people – about 20% of its population, including 70% of people over the age of 60. And it is set to have some 5.2 million people completely […] Continue reading -> Rapid Increase In COVID Cases ‘Not Due To The Variant’, WHO Says 12/01/2021 J Hacker The “almost vertical” spike in SARS-CoV-2 infections seen in many countries over the last few weeks is largely due to increased social contact and not virus mutations, WHO has said. Speaking at a media briefing on Monday, Dr Maria Van Kerkhove, WHO’s COVID-19 Technical Lead, stated that sharp increases in transmission had occurred in a […] Continue reading -> Switzerland Approves Moderna COVID Vaccine, As Pharma Company Claims Vaccine Could Confer Year Of Immunity – At Least 12/01/2021 J Hacker Switzerland’s drug regulatory agency, Swissmedic, has authorized Moderna’s mRNA COVID-19 vaccine for use – in a move that should helop accelerate its rollout of vaccines against the pandemic, The Swiss Federal Government has secured 7.5 million doses of the Moderna vaccine, with deliveries expected to begin next week from the Visp-based plant where most of […] Continue reading -> €93 Billion Spent By Public Sector On COVID Vaccines and Therapeutics in 11 Months, Research Finds 12/01/2021 Madeleine Hoecklin Governments have spent at least €93 billion on COVID-19 vaccines and therapeutics globally since the beginning of the pandemic, a new study has found. Research published on Monday by the kENUP Foundation, a European non-profit supporting research-based innovation in health industries, found that in 11 months, the public sector invested heavily in the development of […] Continue reading -> COVID Extremes: Most Hospitalized Patients Still Have Symptoms 6 Months Later; But Asymptomatic Cases Are Driving Transmission 09/01/2021 Madeleine Hoecklin Two new studies published this week highlight the challenges to health policy posed by COVID-19 – with seriously ill COVID-19 patients continuing to suffer with “Long COVID” months after being released from the hospital – while completely asymptomatic cases drive more than half of overall disease transmission. More than three quarters of patients diagnosed with […] Continue reading -> EMA Approves Moderna’s COVID-19 Vaccine – US Experts Examine Halving Doses To Extend Supplies 06/01/2021 Madeleine Hoecklin The European Medicines Agency (EMA), the EU drug regulator, recommended issuing a conditional marketing authorization for Moderna’s COVID-19 vaccine, which follows the authorization of the Pfizer-BioNTech vaccine in late December. “This vaccine provides us with another tool to overcome the current emergency,” Emer Cooke, Executive Director of EMA, said in the press release. “It is […] Continue reading -> People Who Have Had COVID Can Delay Vaccine Up To 6 Months, Says WHO 05/01/2021 J Hacker Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 People who have recently had a confirmed COVID-19 infection can choose to delay vaccination, so as to allow others who are not immune take advantage of initial procurements, WHO has recommended. Following WHO’s approval of the Pfizer/BioNTech vaccine last week, its strategic advisory group of experts (SAGE) said that if a person has had a […] Continue reading -> Israel Approves Moderna’s COVID-19 Vaccine – First Country Outside North America 05/01/2021 Elaine Ruth Fletcher BREAKING – Israel’s Ministry of Health on Tuesday approved the administration of Moderna’s COVID-19 vaccine, making it the first country outside of North America to greenlight the US-based startup’s candidate. The announcement by Moderna said that deliveries of the vaccine to Israel would begin already in January – sharply advancing a schedule that was originally […] Continue reading -> UK Delay of Second COVID-19 Vaccine Dose – A Risky Strategy That Could Give Rise To More Virus Mutations, Some Experts Warn 04/01/2021 Madeleine Hoecklin The United Kingdom’s decision to delay the second dose of the Pfizer/BioNTech COVID-19 vaccine being rolled out en masse in the nation is a risky strategy – not only for those getting the vaccine, but also in terms of the longer-term public health impacts such delays could have in terms of future SARS-CoV2 mutations, some […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Rapid Increase In COVID Cases ‘Not Due To The Variant’, WHO Says 12/01/2021 J Hacker The “almost vertical” spike in SARS-CoV-2 infections seen in many countries over the last few weeks is largely due to increased social contact and not virus mutations, WHO has said. Speaking at a media briefing on Monday, Dr Maria Van Kerkhove, WHO’s COVID-19 Technical Lead, stated that sharp increases in transmission had occurred in a […] Continue reading -> Switzerland Approves Moderna COVID Vaccine, As Pharma Company Claims Vaccine Could Confer Year Of Immunity – At Least 12/01/2021 J Hacker Switzerland’s drug regulatory agency, Swissmedic, has authorized Moderna’s mRNA COVID-19 vaccine for use – in a move that should helop accelerate its rollout of vaccines against the pandemic, The Swiss Federal Government has secured 7.5 million doses of the Moderna vaccine, with deliveries expected to begin next week from the Visp-based plant where most of […] Continue reading -> €93 Billion Spent By Public Sector On COVID Vaccines and Therapeutics in 11 Months, Research Finds 12/01/2021 Madeleine Hoecklin Governments have spent at least €93 billion on COVID-19 vaccines and therapeutics globally since the beginning of the pandemic, a new study has found. Research published on Monday by the kENUP Foundation, a European non-profit supporting research-based innovation in health industries, found that in 11 months, the public sector invested heavily in the development of […] Continue reading -> COVID Extremes: Most Hospitalized Patients Still Have Symptoms 6 Months Later; But Asymptomatic Cases Are Driving Transmission 09/01/2021 Madeleine Hoecklin Two new studies published this week highlight the challenges to health policy posed by COVID-19 – with seriously ill COVID-19 patients continuing to suffer with “Long COVID” months after being released from the hospital – while completely asymptomatic cases drive more than half of overall disease transmission. More than three quarters of patients diagnosed with […] Continue reading -> EMA Approves Moderna’s COVID-19 Vaccine – US Experts Examine Halving Doses To Extend Supplies 06/01/2021 Madeleine Hoecklin The European Medicines Agency (EMA), the EU drug regulator, recommended issuing a conditional marketing authorization for Moderna’s COVID-19 vaccine, which follows the authorization of the Pfizer-BioNTech vaccine in late December. “This vaccine provides us with another tool to overcome the current emergency,” Emer Cooke, Executive Director of EMA, said in the press release. “It is […] Continue reading -> People Who Have Had COVID Can Delay Vaccine Up To 6 Months, Says WHO 05/01/2021 J Hacker Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 People who have recently had a confirmed COVID-19 infection can choose to delay vaccination, so as to allow others who are not immune take advantage of initial procurements, WHO has recommended. Following WHO’s approval of the Pfizer/BioNTech vaccine last week, its strategic advisory group of experts (SAGE) said that if a person has had a […] Continue reading -> Israel Approves Moderna’s COVID-19 Vaccine – First Country Outside North America 05/01/2021 Elaine Ruth Fletcher BREAKING – Israel’s Ministry of Health on Tuesday approved the administration of Moderna’s COVID-19 vaccine, making it the first country outside of North America to greenlight the US-based startup’s candidate. The announcement by Moderna said that deliveries of the vaccine to Israel would begin already in January – sharply advancing a schedule that was originally […] Continue reading -> UK Delay of Second COVID-19 Vaccine Dose – A Risky Strategy That Could Give Rise To More Virus Mutations, Some Experts Warn 04/01/2021 Madeleine Hoecklin The United Kingdom’s decision to delay the second dose of the Pfizer/BioNTech COVID-19 vaccine being rolled out en masse in the nation is a risky strategy – not only for those getting the vaccine, but also in terms of the longer-term public health impacts such delays could have in terms of future SARS-CoV2 mutations, some […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Switzerland Approves Moderna COVID Vaccine, As Pharma Company Claims Vaccine Could Confer Year Of Immunity – At Least 12/01/2021 J Hacker Switzerland’s drug regulatory agency, Swissmedic, has authorized Moderna’s mRNA COVID-19 vaccine for use – in a move that should helop accelerate its rollout of vaccines against the pandemic, The Swiss Federal Government has secured 7.5 million doses of the Moderna vaccine, with deliveries expected to begin next week from the Visp-based plant where most of […] Continue reading -> €93 Billion Spent By Public Sector On COVID Vaccines and Therapeutics in 11 Months, Research Finds 12/01/2021 Madeleine Hoecklin Governments have spent at least €93 billion on COVID-19 vaccines and therapeutics globally since the beginning of the pandemic, a new study has found. Research published on Monday by the kENUP Foundation, a European non-profit supporting research-based innovation in health industries, found that in 11 months, the public sector invested heavily in the development of […] Continue reading -> COVID Extremes: Most Hospitalized Patients Still Have Symptoms 6 Months Later; But Asymptomatic Cases Are Driving Transmission 09/01/2021 Madeleine Hoecklin Two new studies published this week highlight the challenges to health policy posed by COVID-19 – with seriously ill COVID-19 patients continuing to suffer with “Long COVID” months after being released from the hospital – while completely asymptomatic cases drive more than half of overall disease transmission. More than three quarters of patients diagnosed with […] Continue reading -> EMA Approves Moderna’s COVID-19 Vaccine – US Experts Examine Halving Doses To Extend Supplies 06/01/2021 Madeleine Hoecklin The European Medicines Agency (EMA), the EU drug regulator, recommended issuing a conditional marketing authorization for Moderna’s COVID-19 vaccine, which follows the authorization of the Pfizer-BioNTech vaccine in late December. “This vaccine provides us with another tool to overcome the current emergency,” Emer Cooke, Executive Director of EMA, said in the press release. “It is […] Continue reading -> People Who Have Had COVID Can Delay Vaccine Up To 6 Months, Says WHO 05/01/2021 J Hacker Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 People who have recently had a confirmed COVID-19 infection can choose to delay vaccination, so as to allow others who are not immune take advantage of initial procurements, WHO has recommended. Following WHO’s approval of the Pfizer/BioNTech vaccine last week, its strategic advisory group of experts (SAGE) said that if a person has had a […] Continue reading -> Israel Approves Moderna’s COVID-19 Vaccine – First Country Outside North America 05/01/2021 Elaine Ruth Fletcher BREAKING – Israel’s Ministry of Health on Tuesday approved the administration of Moderna’s COVID-19 vaccine, making it the first country outside of North America to greenlight the US-based startup’s candidate. The announcement by Moderna said that deliveries of the vaccine to Israel would begin already in January – sharply advancing a schedule that was originally […] Continue reading -> UK Delay of Second COVID-19 Vaccine Dose – A Risky Strategy That Could Give Rise To More Virus Mutations, Some Experts Warn 04/01/2021 Madeleine Hoecklin The United Kingdom’s decision to delay the second dose of the Pfizer/BioNTech COVID-19 vaccine being rolled out en masse in the nation is a risky strategy – not only for those getting the vaccine, but also in terms of the longer-term public health impacts such delays could have in terms of future SARS-CoV2 mutations, some […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
€93 Billion Spent By Public Sector On COVID Vaccines and Therapeutics in 11 Months, Research Finds 12/01/2021 Madeleine Hoecklin Governments have spent at least €93 billion on COVID-19 vaccines and therapeutics globally since the beginning of the pandemic, a new study has found. Research published on Monday by the kENUP Foundation, a European non-profit supporting research-based innovation in health industries, found that in 11 months, the public sector invested heavily in the development of […] Continue reading -> COVID Extremes: Most Hospitalized Patients Still Have Symptoms 6 Months Later; But Asymptomatic Cases Are Driving Transmission 09/01/2021 Madeleine Hoecklin Two new studies published this week highlight the challenges to health policy posed by COVID-19 – with seriously ill COVID-19 patients continuing to suffer with “Long COVID” months after being released from the hospital – while completely asymptomatic cases drive more than half of overall disease transmission. More than three quarters of patients diagnosed with […] Continue reading -> EMA Approves Moderna’s COVID-19 Vaccine – US Experts Examine Halving Doses To Extend Supplies 06/01/2021 Madeleine Hoecklin The European Medicines Agency (EMA), the EU drug regulator, recommended issuing a conditional marketing authorization for Moderna’s COVID-19 vaccine, which follows the authorization of the Pfizer-BioNTech vaccine in late December. “This vaccine provides us with another tool to overcome the current emergency,” Emer Cooke, Executive Director of EMA, said in the press release. “It is […] Continue reading -> People Who Have Had COVID Can Delay Vaccine Up To 6 Months, Says WHO 05/01/2021 J Hacker Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 People who have recently had a confirmed COVID-19 infection can choose to delay vaccination, so as to allow others who are not immune take advantage of initial procurements, WHO has recommended. Following WHO’s approval of the Pfizer/BioNTech vaccine last week, its strategic advisory group of experts (SAGE) said that if a person has had a […] Continue reading -> Israel Approves Moderna’s COVID-19 Vaccine – First Country Outside North America 05/01/2021 Elaine Ruth Fletcher BREAKING – Israel’s Ministry of Health on Tuesday approved the administration of Moderna’s COVID-19 vaccine, making it the first country outside of North America to greenlight the US-based startup’s candidate. The announcement by Moderna said that deliveries of the vaccine to Israel would begin already in January – sharply advancing a schedule that was originally […] Continue reading -> UK Delay of Second COVID-19 Vaccine Dose – A Risky Strategy That Could Give Rise To More Virus Mutations, Some Experts Warn 04/01/2021 Madeleine Hoecklin The United Kingdom’s decision to delay the second dose of the Pfizer/BioNTech COVID-19 vaccine being rolled out en masse in the nation is a risky strategy – not only for those getting the vaccine, but also in terms of the longer-term public health impacts such delays could have in terms of future SARS-CoV2 mutations, some […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID Extremes: Most Hospitalized Patients Still Have Symptoms 6 Months Later; But Asymptomatic Cases Are Driving Transmission 09/01/2021 Madeleine Hoecklin Two new studies published this week highlight the challenges to health policy posed by COVID-19 – with seriously ill COVID-19 patients continuing to suffer with “Long COVID” months after being released from the hospital – while completely asymptomatic cases drive more than half of overall disease transmission. More than three quarters of patients diagnosed with […] Continue reading -> EMA Approves Moderna’s COVID-19 Vaccine – US Experts Examine Halving Doses To Extend Supplies 06/01/2021 Madeleine Hoecklin The European Medicines Agency (EMA), the EU drug regulator, recommended issuing a conditional marketing authorization for Moderna’s COVID-19 vaccine, which follows the authorization of the Pfizer-BioNTech vaccine in late December. “This vaccine provides us with another tool to overcome the current emergency,” Emer Cooke, Executive Director of EMA, said in the press release. “It is […] Continue reading -> People Who Have Had COVID Can Delay Vaccine Up To 6 Months, Says WHO 05/01/2021 J Hacker Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 People who have recently had a confirmed COVID-19 infection can choose to delay vaccination, so as to allow others who are not immune take advantage of initial procurements, WHO has recommended. Following WHO’s approval of the Pfizer/BioNTech vaccine last week, its strategic advisory group of experts (SAGE) said that if a person has had a […] Continue reading -> Israel Approves Moderna’s COVID-19 Vaccine – First Country Outside North America 05/01/2021 Elaine Ruth Fletcher BREAKING – Israel’s Ministry of Health on Tuesday approved the administration of Moderna’s COVID-19 vaccine, making it the first country outside of North America to greenlight the US-based startup’s candidate. The announcement by Moderna said that deliveries of the vaccine to Israel would begin already in January – sharply advancing a schedule that was originally […] Continue reading -> UK Delay of Second COVID-19 Vaccine Dose – A Risky Strategy That Could Give Rise To More Virus Mutations, Some Experts Warn 04/01/2021 Madeleine Hoecklin The United Kingdom’s decision to delay the second dose of the Pfizer/BioNTech COVID-19 vaccine being rolled out en masse in the nation is a risky strategy – not only for those getting the vaccine, but also in terms of the longer-term public health impacts such delays could have in terms of future SARS-CoV2 mutations, some […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
EMA Approves Moderna’s COVID-19 Vaccine – US Experts Examine Halving Doses To Extend Supplies 06/01/2021 Madeleine Hoecklin The European Medicines Agency (EMA), the EU drug regulator, recommended issuing a conditional marketing authorization for Moderna’s COVID-19 vaccine, which follows the authorization of the Pfizer-BioNTech vaccine in late December. “This vaccine provides us with another tool to overcome the current emergency,” Emer Cooke, Executive Director of EMA, said in the press release. “It is […] Continue reading -> People Who Have Had COVID Can Delay Vaccine Up To 6 Months, Says WHO 05/01/2021 J Hacker Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 People who have recently had a confirmed COVID-19 infection can choose to delay vaccination, so as to allow others who are not immune take advantage of initial procurements, WHO has recommended. Following WHO’s approval of the Pfizer/BioNTech vaccine last week, its strategic advisory group of experts (SAGE) said that if a person has had a […] Continue reading -> Israel Approves Moderna’s COVID-19 Vaccine – First Country Outside North America 05/01/2021 Elaine Ruth Fletcher BREAKING – Israel’s Ministry of Health on Tuesday approved the administration of Moderna’s COVID-19 vaccine, making it the first country outside of North America to greenlight the US-based startup’s candidate. The announcement by Moderna said that deliveries of the vaccine to Israel would begin already in January – sharply advancing a schedule that was originally […] Continue reading -> UK Delay of Second COVID-19 Vaccine Dose – A Risky Strategy That Could Give Rise To More Virus Mutations, Some Experts Warn 04/01/2021 Madeleine Hoecklin The United Kingdom’s decision to delay the second dose of the Pfizer/BioNTech COVID-19 vaccine being rolled out en masse in the nation is a risky strategy – not only for those getting the vaccine, but also in terms of the longer-term public health impacts such delays could have in terms of future SARS-CoV2 mutations, some […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
People Who Have Had COVID Can Delay Vaccine Up To 6 Months, Says WHO 05/01/2021 J Hacker Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 People who have recently had a confirmed COVID-19 infection can choose to delay vaccination, so as to allow others who are not immune take advantage of initial procurements, WHO has recommended. Following WHO’s approval of the Pfizer/BioNTech vaccine last week, its strategic advisory group of experts (SAGE) said that if a person has had a […] Continue reading -> Israel Approves Moderna’s COVID-19 Vaccine – First Country Outside North America 05/01/2021 Elaine Ruth Fletcher BREAKING – Israel’s Ministry of Health on Tuesday approved the administration of Moderna’s COVID-19 vaccine, making it the first country outside of North America to greenlight the US-based startup’s candidate. The announcement by Moderna said that deliveries of the vaccine to Israel would begin already in January – sharply advancing a schedule that was originally […] Continue reading -> UK Delay of Second COVID-19 Vaccine Dose – A Risky Strategy That Could Give Rise To More Virus Mutations, Some Experts Warn 04/01/2021 Madeleine Hoecklin The United Kingdom’s decision to delay the second dose of the Pfizer/BioNTech COVID-19 vaccine being rolled out en masse in the nation is a risky strategy – not only for those getting the vaccine, but also in terms of the longer-term public health impacts such delays could have in terms of future SARS-CoV2 mutations, some […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Israel Approves Moderna’s COVID-19 Vaccine – First Country Outside North America 05/01/2021 Elaine Ruth Fletcher BREAKING – Israel’s Ministry of Health on Tuesday approved the administration of Moderna’s COVID-19 vaccine, making it the first country outside of North America to greenlight the US-based startup’s candidate. The announcement by Moderna said that deliveries of the vaccine to Israel would begin already in January – sharply advancing a schedule that was originally […] Continue reading -> UK Delay of Second COVID-19 Vaccine Dose – A Risky Strategy That Could Give Rise To More Virus Mutations, Some Experts Warn 04/01/2021 Madeleine Hoecklin The United Kingdom’s decision to delay the second dose of the Pfizer/BioNTech COVID-19 vaccine being rolled out en masse in the nation is a risky strategy – not only for those getting the vaccine, but also in terms of the longer-term public health impacts such delays could have in terms of future SARS-CoV2 mutations, some […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
UK Delay of Second COVID-19 Vaccine Dose – A Risky Strategy That Could Give Rise To More Virus Mutations, Some Experts Warn 04/01/2021 Madeleine Hoecklin The United Kingdom’s decision to delay the second dose of the Pfizer/BioNTech COVID-19 vaccine being rolled out en masse in the nation is a risky strategy – not only for those getting the vaccine, but also in terms of the longer-term public health impacts such delays could have in terms of future SARS-CoV2 mutations, some […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy